DNA methylation markers – an opportunity to further individualize therapy in breast cancer?

Author： Maier Sabine   Lesche Ralf   Nimmrich Inko   Eckhardt Florian   Dahlstroem Christina   Plum Achim  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.2, Iss.4, 2005-11, pp. : 339-347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sentinel Node Biopsy in Anal Cancer – a Promising Strategy to Individualize Therapy

By  

Oncology Research and Treatment, Vol. 26, Iss. 5, 2003-11 ,pp. : 456-460

Karger

Access to resources Recommend Favorite

Chemotherapy‐related aortic remodelling

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 2, 2015-02 ,pp. : 140-147

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular markers for breast cancer diagnosis, prognosis and targeted therapy

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 1, 2015-01 ,pp. : 81-90

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comprehensive DNA Methylation and Extensive Mutation Analyses of HER2-Positive Breast Cancer

By  

Oncology, Vol. 88, Iss. 6, 2015-0 ,pp. : 377-384

Karger

Access to resources Recommend Favorite

Methylated DNA and Total DNA in Serum Detected by One-Step Methylation-Specific PCR Is Predictive of Poor Prognosis for Breast Cancer Patients

By  

Oncology, Vol. 83, Iss. 5, 2012-09 ,pp. : 273-282

Karger

Access to resources Recommend Favorite